Login To Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Portfolio Login
Sensex
18,719.29
-526.41
-2.74%
Nifty
5,655.90
-166.35
-2.86%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Cadila Healthcare Ltd
BSE: 532321 | NSE: CADILAHC | ISIN: INE010B01019
Market Cap: [Rs.Cr.] 16,246 | Face Value: [Rs.] 5
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Discuss this stock
Finished Goods
Mar 2012
Mar 2011
Mar 2010
Mar 2009
Mar 2008
Mar 2007
Mar 2006
Mar 2005
Mar 2004
Mar 2003
Product Name
Unit
value (Rs.Cr)
Qty (Nos.)
%Sales Turnover
Sales
NA
0.00
0
0.00
Other Operating Revenues
NA
737.50
0
23.09
Contract Manufacturings
NA
0.00
0
0.00
Others
NA
12.20
0
0.38
Suppositories
NA
13.30
0
0.42
Transdermals
NA
1.90
0
0.06
Vaccines
NA
21.90
0
0.69
Bulk Drugs
NA
315.50
0
9.88
Aerosols
NA
45.90
0
1.44
Capsules
NA
257.70
0
8.07
Dry Syrups/Powders
NA
57.90
0
1.81
Dry Syrups/Powders/Injectables
NA
104.90
0
3.28
Injections
NA
249.40
0
7.81
Lyophised Injections
NA
20.30
0
0.64
Ointment
NA
37.40
0
1.17
Tablets
NA
1,276.10
0
39.95
Cosmetics
NA
0.10
0
0.00
Liquids
NA
42.00
0
1.31
India Infoline Research
Company
|
Sectors
Pankaj Patel, Chairman and Managing Director, Zydus Cadila
Related News
Company
|
Sector
|
Latest
11-Jun-13
Cadila Healthcare drops ex-dividend
05-Jun-13
Cadila Healthcare in reverse gear
05-Jun-13
Cadila Healthcare up almost 1% on talks of a strategic announcement
05-Jun-13
Cadila Healthcare to make strategic announcement
04-Jun-13
Cadila Healthcare jumps ahead of press conference
04-Jun-13
Cadila Healthcare
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Sun Pharma.Inds.
99,536.69
192.62
12.78
27.45
26.1
27.0
0.01
Dr Reddy's Labs
35,691.50
28.20
4.69
18.79
14.3
16.6
0.25
Cipla
30,498.16
20.24
3.44
14.11
15.9
19.8
0.03
Cadila Health.
16,246.12
34.82
5.64
18.45
28.4
24.2
0.40
Glenmark Pharma.
15,472.45
40.08
6.13
23.94
12.7
11.7
0.39
Ranbaxy Labs.
14,984.09
0.00
7.80
72.87
0.0
0.0
2.38
Wockhardt
11,962.85
32.47
14.62
12.82
237.0
30.3
2.09
Piramal Enterp.
9,614.49
0.00
0.91
23.66
0.8
2.1
0.07
Ipca Labs.
8,769.01
26.46
5.59
10.09
24.2
23.7
0.49
Torrent Pharma.
7,166.47
12.43
4.34
11.66
29.6
25.5
0.48
Biocon
5,512.00
19.22
2.50
12.20
12.6
13.6
0.08
Aurobindo Pharma
5,279.46
10.65
1.80
22.89
10.7
8.8
1.01
Strides Arcolab
5,002.13
34.10
3.65
46.94
7.3
8.9
0.56
Mylan Lab.
3,273.19
6.80
1.77
0.00
26.9
26.1
0.59
Alembic Pharma
2,739.85
17.41
5.96
5.60
39.5
27.7
1.07
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
Pankaj R Patel , Chairman & Managing Director
Sharvil P Patel , Deputy Managing Director
Mukesh M Patel , Director
H Dhanrajgir , Director
Company Head Office / Quarters:
Zydus Tower,
Satellite Cross Roads,
Ahmedabad,
Gujarat-380015
Phone : 91-79-26868100
Fax : 91-79-26862366/5
E-mail :
investor.grievance@zyduscadila.com
Web :
http://www.zyduscadila.com
Registrars:
Sharepro Services India P Ltd
Samhita Complex
Plot No 13 AB
Saki Naka Andheri(E)
Mumbai-400072
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
Franklin India Bluechip Fund - (G)
1,300,000
SBI Magnum Tax Gain Scheme (D)
1,086,846
ICICI Pru Dynamic Plan (G)
1,009,590
Detailed List
Calendar
Jun-2013
M
T
W
T
F
S
S
17
18
19
20
21
22
23
IPO
No IPO today
View full month IPO calendar
Economic Events
ANZ Job Advertisements (MoM)
EIA Natural Gas Storage Change
View full month Economic Events calendar
Results
Havells India | Union Bank (I) | Dena Bank | Central Bank
View full month Results calendar